b
r
c
coronavirus
cov
caus
lifethreaten
respiratori
diseas
infecti
entri
requir
viral
spike
protein
attach
cell
receptor
undergo
proteolyt
cleavag
refold
process
catalyz
viruscel
membran
fusion
fusioninhibit
peptid
bind
protein
interfer
refold
prevent
infect
conjug
fusioninhibit
peptid
variou
lipid
expect
secur
peptid
onto
cell
membran
therebi
increas
antivir
potenc
cholesterol
palmit
adduct
increas
antivir
potenc
antivir
effect
evid
proteolyt
cleavag
impli
lipid
conjug
affix
peptid
site
proteasetrigg
fusion
activ
unlik
lipidfre
peptid
lipopeptid
suppress
cov
proteindirect
viru
entri
take
place
within
endosom
cell
imag
reveal
intracellular
peptid
aggreg
consist
endocytosi
compart
cov
entri
take
place
find
suggest
lipid
local
antivir
peptid
proteaserich
site
cov
fusion
therebi
protect
cell
divers
cov
coronavirus
cov
envelop
rna
virus
infect
respiratori
enter
tract
bird
mammal
virul
host
anim
vari
asymptot
lifethreaten
depend
infect
viru
type
host
suscept
determin
channappanavar
perlman
de
wit
et
al
graham
et
al
weiss
navasmartin
weiss
leibowitz
cov
known
zoonot
transmiss
human
reveal
sudden
emerg
sever
acut
respiratori
syndrom
sar
lau
et
al
li
et
al
middl
east
respiratori
syndrom
mer
annan
et
al
anthoni
et
al
memish
et
al
antivir
agent
limit
merscov
newlyemerg
cov
infect
reduc
diseas
burden
quell
fear
futur
epidem
origin
zoonot
cov
cov
spike
protein
eman
infect
viru
particl
adher
cellular
receptor
target
cell
catalyz
viral
envelopecellular
membran
fusion
belouzard
et
al
simmon
et
al
atomicresolut
structur
known
five
cov
protein
gui
et
al
kirchdoerf
et
al
wall
et
al
wall
et
al
yuan
et
al
kda
homotrim
monom
compris
sever
domain
receptorbind
domain
rbd
distant
virion
envelop
fusioncatalyz
domain
fd
virusproxim
buri
underneath
canopi
rbd
similar
fusioncatalyz
protein
envelop
virus
cov
protein
produc
inact
prefus
state
becom
activ
ie
capabl
catalyz
membran
fusion
undergo
structur
transit
cell
entri
environment
factor
control
protein
activ
encount
cell
entri
includ
cellular
receptor
bind
particular
protein
conform
gui
et
al
may
promot
fusionreadi
state
park
et
al
zelu
et
al
second
factor
cellular
proteas
cleav
protein
permit
structur
chang
belouzard
et
al
matsuyama
et
al
simmon
et
al
mani
detail
structur
dynam
remain
unknown
current
specul
receptor
bind
proteolysi
expos
fd
allow
hydrophob
fusion
peptid
portion
emb
target
cell
membran
yuan
et
al
result
put
alphahel
extend
fusion
intermedi
link
virus
host
cell
undefin
time
period
collaps
concert
coalesc
viral
cell
membran
postfus
fd
highlyst
perman
inact
collaps
antiparallel
helic
bundl
bosch
et
al
gao
et
al
lu
et
al
peptid
highli
similar
ident
membraneproxim
portion
protein
fd
block
fusion
process
therebi
prevent
cov
infect
amino
acid
peptid
design
heptad
repeat
peptid
bind
fd
region
call
form
antiparallel
helic
bundl
peptid
bind
fusion
intermedi
preand
postfus
protein
interfer
refold
postfus
fd
bosch
et
al
mcreynold
et
al
xu
et
al
xu
et
al
mani
envelop
virus
undergo
similar
fusion
catalysi
includ
human
immunodefici
viru
jiang
et
al
wild
et
al
paramyxovirus
lambert
et
al
rapaport
et
al
young
et
al
flavivirus
hrobowski
et
al
subject
analog
suppress
fusioninhibitori
peptid
howev
cov
peptid
inhibit
viru
infect
micromolar
rang
bosch
et
al
gao
et
al
liu
et
al
lu
et
al
xu
et
al
therefor
weakli
antivir
least
comparison
peptid
prevent
hivcel
entri
present
low
nanomolar
concentr
wild
et
al
one
explan
modest
antivir
activ
cov
fd
intermedi
form
subcellular
locat
access
peptid
inaccess
locat
may
within
membran
microdomain
choi
et
al
earnest
et
al
lu
et
al
nomura
et
al
thorp
gallagh
within
endosom
bosch
et
al
kawas
et
al
qiu
et
al
shah
et
al
simmon
et
al
proteaseenrich
locat
one
might
expect
facilit
protein
activ
exogenouslyad
peptid
may
accumul
proteaseenrich
subcellular
environ
result
somewhat
modest
antivir
effect
thu
specul
peptid
might
increas
antivir
potenc
concentr
locat
sdirect
fusion
take
place
present
studi
provid
evid
cov
protein
must
proteolyz
form
fusion
intermedi
target
peptid
evalu
adduct
might
concentr
peptid
proteaserich
region
find
indic
lipid
adduct
greatli
increas
peptid
antivir
activ
suggest
lipid
peptid
accumul
locat
incom
virus
undergo
transit
fusion
intermedi
peptid
use
studi
design
jiang
colleagu
lu
et
al
engin
specif
inhibit
merscov
channappanavar
et
al
gao
et
al
lu
et
al
studi
evalu
lipophil
deriv
mer
peptid
customsynthes
peptid
prepar
american
peptid
compani
sunnyval
ca
includ
ctermin
glycineserineglycin
gsg
linker
four
ethylen
glycol
particular
lipid
moieti
fig
lipid
select
basi
incorpor
differ
membran
microdomain
cholesterol
palmit
chosen
emb
lipid
raft
schumann
et
al
tocopherol
select
differenti
inclus
polyunsatur
fatti
acid
pufa
enrich
nonraft
like
domain
atkinson
et
al
raederstorff
et
al
cov
receptor
proteas
transmembraneanchor
enrich
lipid
raftlik
microdomain
earnest
et
al
le
naour
et
al
rana
et
al
make
like
protein
intermedi
form
restrict
membran
locat
therefor
peptid
might
extraordinarili
antivir
ctermin
embed
near
microdomain
might
case
cholesterol
palmit
perhap
tocopherolconjug
peptid
ask
whether
lipidconjug
mer
peptid
inhibit
cov
infect
first
viru
evalu
mous
hepat
viru
mhv
betacov
moder
homolog
merscov
van
boheemen
et
al
site
bind
ie
target
site
similar
merscov
protein
fig
human
cell
express
mhv
receptor
carcinoembryon
antigenrel
cell
adhes
molecul
william
et
al
incub
one
hour
grade
dose
lipopeptid
challeng
recombin
mhv
strain
encod
firefli
luciferas
fluc
report
shulla
gallagh
infect
measur
fluc
accumul
potent
reduc
concentr
cholesteroland
palmitatetag
peptid
respect
fig
contrast
infect
reduc
tocopheroland
peptid
fig
valu
cholesteroland
peptid
nm
find
indic
lipid
potent
increas
antivir
activ
extend
antivir
activ
cov
moder
ident
merscov
see
fig
focu
specif
viruscel
entri
stage
next
ask
whether
lipopeptid
arrest
proteindriven
cell
entri
accomplish
use
human
immunodefici
viru
hiv
base
pseudoparticl
pp
contain
cov
protein
cov
protein
transduc
hiv
genomeencod
fluc
gene
thu
fluc
accumul
target
cell
reflect
sdirect
viru
entri
construct
pp
display
mhv
strain
protein
transduc
receptorbear
cell
subsequ
extent
transduct
measur
luciferas
accumul
result
parallel
observ
evalu
authent
mhv
infect
compar
fig
find
demonstr
antivir
effect
oper
entir
cell
entri
stage
also
engend
confid
pp
transduct
reflect
authent
covcel
entri
event
use
valid
pp
transduct
approach
determin
whether
peptid
block
sever
differ
sdirect
viru
entri
process
construct
pp
control
vesicular
stomat
viru
vsv
glycoprotein
g
protein
mer
sar
human
cov
strain
protein
target
cell
pp
establish
transfect
necessari
cellular
receptor
human
dipeptidyl
mer
pp
raj
et
al
human
angiotensinconvert
enzym
sar
pp
li
et
al
human
aminopeptidas
n
apn
pp
yeager
et
al
cell
transduc
presenc
grade
dose
condit
vsv
pp
transduct
unaffect
fig
sar
pp
transduct
significantli
reduc
palmitatetag
peptid
fig
compar
zero
palm
howev
mer
pp
transduct
reduc
pattern
similar
mhv
cholesteroland
palmitatetag
peptid
nm
rang
tocopheroltag
peptid
less
convinc
antivir
effect
fig
result
indic
covalentlyattach
lipid
cholesterol
palmit
significantli
increas
antivir
potenc
palmit
also
broaden
antivir
activ
spectrum
even
spike
diverg
target
site
see
fig
exceedingli
weak
antivir
activ
lipidfre
peptid
appear
inconsist
nearli
ident
abl
protect
mice
merscov
infect
mous
lung
channappanavar
et
al
therefor
consid
whether
peptid
particularli
lipidfre
might
evid
antivir
cell
type
whether
particular
cellular
factor
correl
antivir
effect
two
cell
type
select
human
lungderiv
cell
line
shen
et
al
standard
line
propag
human
cov
found
lipidfre
peptid
show
signific
antivir
effect
cell
line
fig
find
prompt
attempt
identifi
cell
typespecif
factor
account
differenti
antivir
potenc
merscov
princip
cell
entri
factor
includ
viru
receptor
fusiontrigg
proteas
transmembran
proteas
tmpr
serin
subtyp
shirato
et
al
furin
millet
whittak
cathepsin
l
qian
et
al
use
quantit
rtpcr
measur
rel
transcript
level
factor
two
cell
line
four
factor
clearli
variabl
undetect
cell
line
fig
address
possibl
correl
proteas
antivir
activ
evalu
merspp
entri
presenc
camostat
specif
tmpr
inhibitor
shirato
et
al
two
test
cell
line
antivir
activ
camostat
residu
interact
target
highlight
bold
font
b
sequenc
similar
target
merscov
sarscov
mhv
strain
shown
similar
score
calcul
use
align
softwar
http
wwwuniprotorgalign
indic
similar
target
merscov
residu
interact
peptid
highlight
bold
font
residu
locat
noninteract
region
shade
gray
error
bar
present
sd
mean
n
statist
signific
assess
student
ttest
p
p
ns
signific
compar
peptid
condit
bracket
right
indic
signific
differ
nonlipid
lipidconjug
peptid
antivir
activ
roughli
similar
agent
potent
antivir
cell
yet
complet
inert
cell
fig
suggest
strong
correl
tmpr
activ
unlipid
antivir
activ
investig
relationship
assess
antivir
activ
differ
tmpr
level
decreas
tmpr
cell
camostat
ad
dose
reduc
mer
pp
entri
normal
fig
mer
pp
transduct
cell
diminish
tmpr
activ
modestli
suppress
peptid
control
condit
full
tmpr
activ
peptid
suppress
pp
fig
increas
tmpr
cell
plasmid
transfect
cell
inocul
mer
pp
peptid
mer
pp
transduct
vero
cell
ectop
suppress
peptid
transduct
controltransfect
vero
cell
unaffect
fig
result
support
hypothesi
protein
cleavag
prerequisit
protein
conform
chang
gener
peptidebind
site
tmpr
mediat
cleavag
cell
surfac
therebi
creat
bind
site
extracellular
unlipid
peptid
cell
mer
pp
traffic
endosom
without
undergo
fusiontrigg
proteolyt
cleavag
becom
fusionactiv
endosom
cystein
proteas
shirato
et
al
sever
cov
requir
similar
endocytosi
prior
cytosol
entri
qiu
et
al
simmon
et
al
ask
whether
mer
pp
entri
endosom
rout
suppress
lipopeptid
cholesteroland
palmitatetag
peptid
reduc
mer
pp
entri
cell
fig
also
suppress
mer
pp
entri
sever
cell
type
known
allow
cov
entri
endosom
fig
c
thu
appear
lipid
adduct
brought
peptid
endosom
bound
inactiv
mer
protein
undergon
cleavag
endosom
cathepsin
valid
content
determin
whether
lipidtag
peptid
specif
block
cov
pp
engin
highli
depend
endocytosi
cleavagetrigg
endosom
cystein
proteas
construct
cov
pp
requir
endosom
proteas
ablat
tmprspecif
proteolyt
substrat
site
leav
cathepsin
site
avail
cleavageactiv
tmpr
furin
substrat
site
mer
cleavag
site
millet
whittak
elimin
mutat
r
sar
syg
mut
protein
compar
wildtyp
wt
proteindirect
pp
entri
cell
wt
mer
pp
entri
modestli
suppress
camostat
tmpr
inhibitor
cystein
proteas
inhibitor
bafilomycin
endosom
acidif
inhibitor
fig
black
bar
find
singl
inhibitor
dramat
reduc
transduct
indic
redund
viru
entri
pathwaysth
wt
protein
direct
entri
either
tmpr
furin
depend
cellsurfac
rout
cystein
proteasedepend
endosom
rout
contrast
mutant
mer
pp
suppress
camostat
potent
block
fig
gray
bar
find
indic
mut
protein
requir
late
endosom
entri
process
endosomerequir
virus
hand
assess
peptid
antivir
activ
lipidfre
peptid
inhibit
wt
mer
pp
concentr
block
lateent
mut
pp
fig
consist
free
extracellular
access
virus
activ
fusion
cell
surfac
tocopherol
tag
peptid
reduc
wt
mutant
mer
pp
equal
modest
potenc
fig
contrast
cholesteroland
palmitatetag
peptid
potent
similarli
inhibit
wt
mutant
mer
transduct
fig
e
determin
whether
lipid
tag
inde
bring
peptid
endosom
lipidfre
cholesterolcontain
peptid
biotinyl
incub
covsuscept
cell
follow
cell
fixat
fluoresc
streptavidin
appli
immunofluoresc
microscopi
use
detect
cellassoci
peptid
method
lipidfre
peptid
never
identifi
cell
neg
data
shown
contrast
peptid
incub
cell
min
detect
insid
cell
definit
puncta
partial
coloc
cholera
toxin
b
ctb
marker
lipid
raftassoci
gangliosid
fig
white
arrow
similar
result
observ
use
biotinyl
peptid
data
shown
collect
result
demonstr
cholesterol
palmit
adduct
allow
antivir
peptid
access
endosom
prevent
viru
fusion
endosom
previou
find
demonstr
mer
pp
avoid
untag
peptid
delay
fusion
trigger
time
endocytosi
specul
mer
pp
proceed
fusion
trigger
littl
delay
might
also
escap
peptid
fusion
intermedi
come
go
quickli
intervent
high
cellsurfac
proteas
level
acceler
covcel
entri
shirato
et
al
hypothes
proteaseacceler
cell
entri
process
might
escap
suppress
effect
question
whether
lipidconjug
peptid
might
captur
block
fastent
virus
address
question
first
determin
pace
mer
pp
entri
cell
measur
entri
kinet
mer
pp
allow
enter
cell
defin
period
halt
entri
ad
proteas
inhibitor
cocktail
extent
transduct
inhibitorarrest
determin
h
later
cell
express
endogen
tmpr
serin
proteas
mer
transduct
acquir
min
incub
fig
solid
line
overexpress
acceler
viru
entri
min
fig
dash
line
inactiv
endogen
tmpr
serin
proteas
camostat
deceler
viru
entri
min
fig
dot
line
result
consist
recent
report
viru
entri
kinet
shirato
et
al
assess
relationship
entri
kinet
sensit
found
unconjug
well
tocopheroland
palmitateconjug
peptid
remain
equal
antivir
fast
slowent
virus
fig
antivir
notabl
cholesterolconjug
show
differenti
antivir
activ
rel
ineffect
block
fastent
mer
pp
fig
result
indic
viru
entri
escap
rapid
entri
lipid
tag
notabl
palmit
posit
arrest
quickact
virus
envelop
viru
fusionblock
peptid
evalu
past
year
candid
antivir
agent
jiang
et
al
lambert
et
al
rapaport
et
al
wild
et
al
young
et
al
studi
becom
clear
peptid
bind
inactiv
viral
envelop
protein
transient
extend
fusion
intermedi
state
kielian
rey
netter
et
al
depend
infect
viru
intermedi
appear
shortli
virusreceptor
bind
may
appear
much
later
virus
engulf
insid
endosom
form
intermedi
may
quickli
induc
fusion
zip
postfus
structur
may
remain
prolong
period
wait
adjac
fusion
intermedi
accumul
cooper
membran
coalesc
compress
postfus
form
ivanov
harrison
exampl
hiv
entri
envelop
protein
convert
prefus
fusionintermedi
form
remain
form
extend
period
time
join
neighbor
intermedi
cooper
pull
membran
togeth
make
rel
longliv
fusion
intermedi
durabl
target
fusion
inhibitori
peptid
reev
et
al
contrastingli
influenza
entri
envelop
protein
convert
prefus
intermedi
form
rel
late
time
viru
endocytosi
cooper
transit
quickli
postfus
state
make
shortliv
endosomerestrict
fusion
intermedi
poorli
target
fusion
inhibitori
peptid
shen
et
al
xu
wilson
cov
set
apart
hiv
influenza
case
variabl
cell
entri
rout
rapid
like
cellsurfac
rout
slower
definit
endosom
rout
depend
time
place
proteasedirect
fusion
trigger
millet
whittak
make
cov
fusion
intermedi
differ
dwell
time
h
unbound
mer
pp
peptid
remov
viru
entri
quantifi
measur
luciferas
level
h
posttransduct
normal
entri
level
absenc
peptid
error
bar
present
sd
mean
n
statist
signific
assess
student
ttest
p
p
p
differ
subcellular
locat
furthermor
target
fusion
inhibitori
peptid
cov
protein
show
consider
varieti
fig
even
diversifi
structur
resist
solubl
peptid
bosch
et
al
therefor
impress
found
singl
inhibitori
peptid
mer
slightli
lesser
extent
mer
block
mani
differ
cov
smediat
cell
entri
process
fig
broad
anticov
activ
attribut
lipid
moieti
claim
place
peptid
near
fusiontrigg
proteas
cholesterol
palmit
associ
lipid
raft
schumann
et
al
enrich
receptor
proteas
activ
merscov
earnest
et
al
le
naour
et
al
rana
et
al
gener
cholesteroland
palmitateadduct
increas
antivir
activ
wherea
tocopherol
fig
thought
incorpor
pufarich
nonraft
domain
atkinson
et
al
raederstorff
et
al
locat
contend
distant
cov
fusiontrigg
proteas
find
add
sever
form
report
demonstr
lipid
tag
increas
antivir
activ
fusionblock
peptid
lee
et
al
porotto
et
al
suggest
singl
lipid
peptid
suppress
wide
rang
pathogen
cov
even
acquir
adapt
mutat
protein
fusion
domain
kim
et
al
scobey
et
al
cholesteroland
palmitateconjug
peptid
also
inhibit
rel
slow
merscov
smediat
entri
take
place
endosom
fig
suggest
two
lipid
tether
peptid
near
virus
throughout
endocytosi
lipid
conjug
allow
peptid
accumul
endosom
therebi
block
slow
enter
virus
recent
document
figueira
et
al
lee
et
al
shown
cov
howev
viru
entri
acceler
overexpress
cholesterolconjug
lost
much
palmit
e
tag
peptid
h
unbound
mer
pp
entri
inhibitor
remov
viru
entri
quantifi
measur
luciferas
level
h
posttransduct
error
bar
present
sd
mean
n
statist
signific
assess
student
ttest
p
p
p
f
cell
incub
biotinyl
peptid
min
cell
stain
biotinyl
peptid
red
gangliosid
green
nuclei
blue
white
arrow
point
puncta
coloc
peptid
gangliosid
fig
effect
high
proteas
level
mer
entri
resist
antivir
peptid
cell
transduc
incub
camostat
cell
incub
mer
pp
h
shift
time
indic
time
point
shift
cell
treat
entri
inhibitor
cocktail
camostat
decrvkrcmk
cell
transduc
mer
pp
presenc
indic
peptid
viru
entri
quantifi
measur
luciferas
level
h
h
posttransduct
error
bar
present
sd
mean
n
statist
signific
assess
student
ttest
p
ns
signific
antivir
potenti
fig
palmitateconjug
fig
may
explain
broader
distribut
cell
surfac
greater
capac
diffus
rapidli
cell
membran
quickli
engag
inactiv
fast
oper
viral
fusion
intermedi
mani
cov
appear
take
fast
cell
entri
rout
inde
peptid
inhibit
mhv
within
postinfect
time
period
shulla
gallagh
indic
cell
entri
process
significantli
rapid
hiv
min
avian
sarcoma
leucosi
viru
subgroup
min
munozbarroso
et
al
netter
et
al
block
fast
slowent
cov
palmitateconjug
peptid
appear
superior
choic
find
report
also
argu
fusiontrigg
proteas
cleav
protein
locat
releas
constraint
allow
protein
convert
intermedi
target
peptid
previou
report
suggest
case
matsuyama
et
al
ujik
et
al
provid
definit
evid
consist
observ
direct
correl
cellsurfac
virusactiv
proteas
antivir
potenc
fig
without
cleavag
substrat
mer
protein
acquir
suscept
solubl
lipidfre
peptid
fig
find
indic
proteolysi
posit
requir
form
protein
structur
import
proteolysi
also
evid
protein
structur
atomicresolut
structur
nativ
cov
protein
kirchdoerf
et
al
wall
et
al
wall
et
al
reveal
complex
fold
buri
set
four
consecut
helic
compris
site
antivir
peptid
bind
held
place
part
interact
domain
distal
virion
avail
postfus
protein
structur
bind
site
continu
helic
trimer
embed
interhel
groov
gao
et
al
lu
et
al
detail
convers
prefus
fusionintermedi
state
unknown
obviou
fairli
dramat
conform
chang
would
requir
releas
helic
allow
interven
looptohelix
transit
linear
helic
trimer
form
current
propos
event
includ
receptordirect
stabil
altern
protein
conform
gui
et
al
may
facilit
exposur
cleavag
site
wall
et
al
subsequ
cleavag
would
expect
liber
bundl
short
helic
loop
extend
long
helic
trimer
report
identifi
relationship
proteas
viruscel
entri
kinet
peptidemedi
antivir
activ
likelihood
peptid
prevent
covcel
entri
depend
proteasedirect
time
locat
protein
convers
fusion
intermedi
peptid
difficulti
access
fusion
intermedi
shortliv
longliv
deep
within
endosom
lipid
tag
peptid
posit
cell
readili
bind
intermedi
provid
broader
potent
antivir
effect
final
note
serin
proteas
inhibitor
consid
potenti
antivir
drug
suppress
cov
kawas
et
al
zhou
et
al
influenza
bahgat
et
al
zhou
et
al
appear
inhibitor
cellsurfac
serin
proteas
drive
cov
slow
endosom
entri
rout
lipidfre
peptid
antivir
activ
find
implic
use
proteas
inhibitor
fusioninhibit
peptid
combin
argu
lipid
peptid
sensibl
choic
futur
combin
therapi
cell
maintain
media
dulbecco
modifi
eagl
media
dmem
supplement
fetal
bovin
serum
fb
atlanta
biolog
norcross
ga
mm
hepe
mm
sodium
pyruv
mm
nonessenti
amino
acid
uml
penicillinstreptomycin
cell
maintain
minimum
essenti
media
mem
supplement
fb
uml
penicillinstreptomycin
cell
maintain
dmem
supplement
fb
mm
hepe
mm
nonessenti
amino
acid
uml
penicillinstreptomycin
cell
maintain
dmem
supplement
fb
u
ml
penicillin
g
streptomycin
delay
brain
tumor
dbt
cell
maintain
mem
supplement
fb
tryptos
phosphat
broth
mm
lglutamin
uml
penicillinstreptomycin
cell
cultur
materi
reagent
obtain
corn
inc
corn
ny
hyclon
logan
ut
unless
otherwis
note
recombin
contain
fluc
report
gene
produc
propag
dbt
cell
describ
previous
shulla
gallagh
viru
entri
measur
fluc
assay
h
postinfect
dna
encod
codonoptim
merscov
genbank
access
number
contain
ctermin
tag
purchas
genscript
inc
piscataway
nj
gener
cleavag
site
mutant
merscov
mer
pcramplifi
mutagen
primer
tabl
pcr
fragment
assembl
use
gibson
assembl
neb
ipswich
sd
construct
confirm
sanger
sequenc
analysi
plasmid
encod
ctermin
flagtag
human
genbank
access
purchas
origen
rockvil
md
plasmid
provid
michael
farzan
scripp
research
institut
plasmid
provid
fang
li
univers
minnesota
pcaggsmhv
strain
previous
construct
boscarino
et
al
phefvsv
g
provid
bei
resourc
manassa
va
previous
construct
shulla
et
al
rewa
obtain
nih
aid
research
refer
program
cat
produc
hiv
pp
cell
transfect
rein
conjunct
plasmid
encod
merscov
sarscov
mhv
vsv
g
use
polyethylenimin
pei
polysci
inc
warrington
pa
cellfre
supernat
contain
pp
collect
h
posttransfect
filter
syring
filter
pall
life
scienc
port
washington
ny
store
use
pseudovirus
normal
transduc
activ
titrat
cell
express
appropri
cov
receptor
normal
particl
concentr
western
blot
use
hiv
antibodi
target
cell
transduc
equival
input
multipl
h
subsequ
wash
incub
addit
h
indic
cell
transfect
apn
use
pei
h
transduct
indic
cell
incub
indic
concentr
camostat
bafilomycin
sigmaaldrich
corpor
h
transduct
transduc
pp
without
remov
previous
appli
inhibitor
end
transduct
period
cell
dissolv
cell
cultur
lysi
buffer
mm
trisphosph
ph
mm
dtt
mm
n
acid
glycerol
triton
luciferas
level
measur
addit
fluc
substrat
mm
dluciferin
mm
atp
mm
mm
hepe
ph
use
verita
micropl
luminomet
turner
biosystem
sunnyval
ca
merscov
peptid
sltqinttlldltyemlslqqvv
kalnesyidlkel
aa
design
describ
previous
lu
et
al
lipidfre
lipidtag
peptid
synthes
american
peptid
compani
inc
sunnyval
ca
kindli
obtain
dr
matteo
porotto
depart
pediatr
columbia
univers
hplc
analys
peptid
prepar
reveal
singl
uniform
peak
reflect
lipopeptid
puriti
peptid
dissolv
dmso
kept
cell
incub
serial
dilut
peptid
h
incub
pp
without
remov
previous
appli
peptid
biotinyl
peptid
cholesterol
tag
peptid
incub
ezlink
sulfonhsbiotin
pierc
rockford
il
min
room
temperatur
reaction
quench
glycin
free
biotin
remov
use
pluson
mini
dialysi
kit
reagent
amersham
bioscienc
san
francisco
ca
cell
incub
biotinyl
peptid
min
cell
fix
permeabl
stain
peptid
gangliosid
g
use
apc
conjug
streptavidin
southern
biotech
birmingham
al
alexa
fluor
conjug
ctb
invitrogen
grand
island
ny
respect
cell
nuclei
stain
hoechst
invitrogen
cell
imag
deltavis
microscop
appli
precis
equip
digit
camera
coolsnap
hq
photometr
use
len
object
imag
deconvolv
softworx
deconvolut
softwar
appli
precis
analyz
use
imari
version
bitplan
scientif
solut
vsvbase
pp
gener
describ
previous
park
et
al
briefli
cell
transfect
mer
use
pei
h
posttransfect
cell
incub
complement
junin
viru
glycoprotein
h
cell
rins
three
time
media
cellfre
supernat
contain
pp
collect
h
posttransfect
filter
syring
filter
pall
life
scienc
port
washington
ny
store
use
entri
kinet
assay
cell
incub
vsv
base
pp
h
unbound
pp
remov
cell
shift
indic
time
point
shift
cell
treat
proteas
inhibitor
cocktail
camostat
decrvkrcmk
h
posttransduct
viru
entri
measur
fluc
assay
total
rna
extract
cell
use
qiagen
rneasi
mini
kit
accord
manufactur
instruct
total
ng
rna
revers
transcrib
use
thermo
scientif
revertaid
rt
kit
waltham
realtim
pcr
perform
quantifi
mrna
express
level
furin
cathepsin
l
hypoxanthineguanin
phosphoribosyltransferas
hprt
use
primer
describ
tabl
rt
sybr
green
qpcr
mastermix
qiagen
express
data
normal
geometr
mean
housekeep
gene
hprt
calcul
ddct
method
experi
independ
repeat
least
three
time
data
present
mean
standard
deviat
sd
statist
signific
calcul
use
holmsidak
multipl
student
ttest
procedur
p
valu
consid
statist
signific
